Drug Clinical Trials List

Study Title	Study Sponsor	Status	Study Drug	Trial Phase	Study Protocol Number	Site
A Randomized, Double-blind, Multicenter, Phase III Study of Everolimus (RAD001) Plus Best Supportive Care Versus Placebo Plus Best Supportive Care in the Treatment of Patients With Advanced NET of GI or Lung Origin - RADIANT-4	Novartis	Completed	RAD001 (Everolimus, Afinitor)	3	CRAD001T2302	KFSH & RC-R
A Randomized, Double-blind, Multi-center, Multi-national Trial to Evaluate the Efficacy, Safety, and Immunogenicity of SAIT101 Versus Rituximab as a First-line Immunotherapy Treatment in Patients with Low Tumor Burden Follicular Lymphoma	Archigen Biotech Limited	Completed	Rituximab / SAIT101	3	AGB 002	PSMMC
A Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, 3-Arm, Parallel-Group Study in Pediatric Subjects Aged 10 Through 17 Years to Evaluate the Efficacy and Safety of BG00012 and BIIB017 for the Treatment of Relapsing-Remitting Multiple Sclerosis	Biogen	Completed	Dimethyl fumarate and PEGylated Interferon Beta-1a	3	800MS301	KKUH
A randomized, double-blind, double-dummy, parallel-group study comparing the efficacy and safety of ofatumumab versus teriflunomide in patients with relapsing multiple sclerosis	Novartis	Ongoing	ofatumumab	3	COMB157G2301	KFSH&RC-J
A Randomized, Double-Blind, Double Dummy, Parallel Group, Multicenter 24 to 52 Week Variable Length Study to Assess the Efficacy and Safety of Budesonide, Glycopyrronium, and Formoterol Fumarate Metered Dose Inhaler (MDI) Relative to Budesonide and Formoterol Fumarate MDI and Symbicort® Pressurized MDI in Adult and Adolescent Participants with Inadequately Controlled Asthma (LOGOS)	AstraZeneca	Ongoing	Budesonide, Glycopyrronium and Formoterol Fumarate	3	D5982C00008	King Abdulaziz University Hospital (Jeddah)
A randomized, double-blind placebo-controlled trial to evaluate the safety and efficacy of a SARS-CoV-2 inactivated vaccine among healthcare workers in Saudi Arabia	KAIMRC	Rejected	SARS-CoV-2 inactivated vaccine (Candidate vaccine) - Sinovac	3	RC20/370/R	King Abdulaziz Medical City NG (Riyadh)
"A randomized, double-blind Phase III study of copanlisib versus placebo in patients with rituximab-refractory indolent non-Hodgkin’s lymphoma (iNHL) – CHRONOS-2"	Bayer	Terminated	BAY 80-6946/Copanlisib	3	BAY 80-6946 / 17322	KAUH-J
A Randomized Trial of Influenza Vaccine to Reduce Adverse Vascular Events: A Pilot Study	McMaster University	Completed	haemagglutinin (HA)/Inactivated Influenza Vaccine Trivalent Types A and B (Split Virion)	3	Version date Sep-3-2013	KKUH
A Randomized Study of the Effect of Maintenance Therapy With Bevacizumab + Capecitabine Versus Bevacizumab Alone on Progression-free Survival in Patients With HER2-negative Metastatic Breast Cancer That Has Not Progressed During First-line Docetaxel Plus Bevacizumab Therapy	Roche	Terminated	Bevacizumab+ Capecitabine	3	MO22223	KAH & OC
A Randomized Phase III Trial of Consolidation with Autologous Hematopoietic Cell Transplantation Followed by Maintenance Rituximab vs. Maintenance Rituximab Alone for Patients with Mantle Cell Lymphoma In Minimal Residual Disease-Negative First Complete Remission	National Cancer Institution	Ongoing	RITUXIMAB	3	EA4151	King Faisal Specialist Hospital and Research Center (Riyadh)